{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:19:27Z","timestamp":1777925967415,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmp.2025.105077","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:16:38Z","timestamp":1756253798000},"page":"105077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Monte Carlo study of the eye lens exposure of medical staff administering Sc-47 and Cu-67 labelled radiopharmaceuticals"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-7626","authenticated-orcid":false,"given":"P.","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-5807","authenticated-orcid":false,"given":"J.","family":"Dabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-7801","authenticated-orcid":false,"given":"J.","family":"Eakins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Krsti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0160-3930","authenticated-orcid":false,"given":"E.","family":"Micha\u015b-Majewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-2708","authenticated-orcid":false,"given":"K.","family":"Tymi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-3930","authenticated-orcid":false,"given":"A.","family":"Benali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5778-9546","authenticated-orcid":false,"given":"R.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-8460","authenticated-orcid":false,"given":"A.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-9716","authenticated-orcid":false,"given":"K.","family":"H\u00fcrkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fioroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmp.2025.105077_b0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2967\/jnumed.118.213496","article-title":"New developments in peptide receptor radionuclide therapy","volume":"60","author":"Nicolas","year":"2019","journal-title":"J Nuclear Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.semnuclmed.2020.05.004","article-title":"Peptide receptor radionuclide therapy of neuroendocrine Tumors","author":"Basu","year":"2020","journal-title":"Sem Nuclear Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0015","first-page":"1","article-title":"Receptor radionuclide therapy in the past 20 years (2000\u20132019): a bibliometric study","volume":"12","author":"Lu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejmp.2025.105077_b0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/j.semnuclmed.2024.02.002","article-title":"Peptide receptor radionuclide therapy of neuroendocrine tumors: agonist, antagonist and alternatives","volume":"54","author":"Santo","year":"2024","journal-title":"Sem Nuclear Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0025","doi-asserted-by":"crossref","unstructured":"O. Sartor, J. de Bono, K.N. Chi, K. Fizazi, K. Herrmann, K. Rahbar, S.T. Tagawa, L.T. Nordquist, N. Vaishampayan, G. El\u2011Haddad, C.H. Park, T.M. Beer, A. Armour, W.J. P\u00e9rez\u2011Contreras, M. DeSilvio, E. Kpamegan, G. Gericke, R.A. Messmann, M.J. Morris, and B.J. Krause Lutetium-177\u2013PSMA-617 for Metastatic Castration-Resistant Prostate Cancer The New England J Med 385;12 nejm.org 16, 2021 1091 \u2013 1103.","DOI":"10.1056\/NEJMoa2107322"},{"key":"10.1016\/j.ejmp.2025.105077_b0030","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","article-title":"Joint EANM\/SNMMI procedure guideline for the use of 177Lu\u2011labeled PSMA\u2011targeted radioligand\u2011therapy (177Lu\u2011PSMA\u2011RLT)","volume":"50","author":"Kratochwil","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ejmp.2025.105077_b0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.semnuclmed.2024.02.007","article-title":"Prostate cancer theranostics with 177Lu-PSMA","volume":"54","author":"Ahmadzadehfar","year":"2024","journal-title":"Sem Nucl Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0040","doi-asserted-by":"crossref","unstructured":"J Harvey Turner theranostics and precision medicine special feature: review article - an introduction to the clinical practice of theranostics in oncology Br J Radiol 2018; 91: 20180440. doi: 10.1259\/bjr.20180440.","DOI":"10.1259\/bjr.20180440"},{"key":"10.1016\/j.ejmp.2025.105077_b0045","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/molecules24030640","article-title":"Therapeutic radiometals: worldwide scientific literature trend analysis (2008\u20132018)","volume":"24","author":"Uccelli","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmp.2025.105077_b0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jlcr.3770","article-title":"Radiometals for imaging and theranostics, current production, and future perspectives","volume":"62","author":"Mikolajczak","year":"2019","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.ejmp.2025.105077_b0055","article-title":"The changing landscape of nuclear medicine and a new era: the \u201cNEW (Nu) CLEAR Medicine\u201d: a framework for the future","volume":"27","author":"Djekidel","year":"2023","journal-title":"Front Nucl Med"},{"issue":"12 Suppl. 2","key":"10.1016\/j.ejmp.2025.105077_b0060","article-title":"The future of nuclear medicine, molecular imaging, and theranostics","volume":"61","author":"Weber","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0065","doi-asserted-by":"crossref","unstructured":"S.C. Vaz, F. Oliveira, K. Hermann and P. Veit-Heibach Nuclear medicine and molecular imaging advances in 21st century. Br J Radiol 93 pp. 20200095 10.1259\/bjr.20200095.","DOI":"10.1259\/bjr.20200095"},{"key":"10.1016\/j.ejmp.2025.105077_b0070","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1007\/s00330-023-09541-z","article-title":"Occupational exposure to ionizing radiation in medical staff: trends during the 2009\u20132019 period in a multicentric study","volume":"33","author":"Baudin","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejmp.2025.105077_b0075","unstructured":"ICRP, 2009. Adult Reference Computational Phantoms. ICRP Publication 110. Ann. ICRP 39 (2)."},{"key":"10.1016\/j.ejmp.2025.105077_b0080","unstructured":"Therapeutic radiopharmaceuticals labelled with copper-67, rhenium-186 and scandium-47 \/ International Atomic Energy Agency. International Atomic Energy Agency, 2021. | Series: IAEA TECDOC series, ISSN 1011\u20134289 ; no. 1945 Vienna (2021)."},{"key":"10.1016\/j.ejmp.2025.105077_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apradiso.2015.04.012","article-title":"Sc-47 production from titanium targets using electron linacs","volume":"102","author":"Mamtimin","year":"2015","journal-title":"Appl Radiation Isotopes"},{"key":"10.1016\/j.ejmp.2025.105077_b0090","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abc811","article-title":"Preliminary dosimetric analysis of DOTA-folate radiopharmaceutical radiolabelled with 47Sc produced through natV(p,x)47Sc cyclotron irradiation","volume":"66","author":"De Nardo","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2025.105077_b0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.apradiso.2017.07.062","article-title":"Sadeghi Mahdi Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose","volume":"129","author":"Deilami-nezhad","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.ejmp.2025.105077_b0100","first-page":"424","article-title":"Therapeutic potential of 47Sc in comparison to 177Lu and 90Y","volume":"11","author":"Siwowska","year":"2019","journal-title":"Preclinical Investigations Pharmaceutics"},{"key":"10.1016\/j.ejmp.2025.105077_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40658-019-0260-0","article-title":"Comparison of scandium-44 g with other PET radionuclides in pre-clinical PET phantom imaging","volume":"6","author":"Ferguson","year":"2019","journal-title":"EJNMMI Phys"},{"issue":"10","key":"10.1016\/j.ejmp.2025.105077_b0110","article-title":"Promising prospects for 44Sc-\/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice","volume":"55","author":"Mueller","year":"2014","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejmp.2025.105077_b0115","first-page":"379","article-title":"Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ejmp.2025.105077_b0120","doi-asserted-by":"crossref","unstructured":"C. B. Johnbeck, U. Knigge, A. Loft, A. K. Berthelsen, J. Mortensen, P. Oturai, S. W. Langer, D. R. Elema and A. Kjaer Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET\/CT: A Prospective Study of 59 Patients with Neuroendocrine, Tumors J Nucl Med 58(3).","DOI":"10.2967\/jnumed.116.180430"},{"key":"10.1016\/j.ejmp.2025.105077_b0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.apradiso.2017.05.024","article-title":"Assessment and estimation of 67Cu production yield via deuteron induced reactions on natZn and 70Zn","volume":"127","author":"Hosseini","year":"2017","journal-title":"Appl Radiation Isotopes"},{"issue":"12","key":"10.1016\/j.ejmp.2025.105077_b0130","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.120.243543","article-title":"Peptide receptor radionuclide therapy with 67Cu-CuSarTATE is highly efficacious against a somatostatin-positive neuroendocrine tumor model","volume":"61","author":"Cullinane","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0135","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abca52","article-title":"Graves Imaging and dosimetric characteristics of 67 Cu","volume":"66","author":"Merrick","year":"2021","journal-title":"Phys Med Biol"},{"issue":"45","key":"10.1016\/j.ejmp.2025.105077_b0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2009960117","article-title":"Harnessing 64Cu\/67Cu for a theranostic approach to pretargeted radioimmunotherapy","volume":"117","author":"Keinanen","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.ejmp.2025.105077_b0145","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.3390\/biomedicines10112787","article-title":"Theragnostic radionuclide pairs for prostate cancer management, can be a budding hot duo","volume":"10","author":"Chhabra","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.ejmp.2025.105077_b0150","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s00259-006-0151-1","article-title":"Tosi Radiation protection in radionuclide therapies with 90Y-conjugates: risks and safety","volume":"33","author":"Cremonesi","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.ejmp.2025.105077_b0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/MNM.0b013e328349fd60","article-title":"Personnel exposure in labelling and administration of 177Lu-DOTA-D-Phe1-Tyr3-octreotide","volume":"32","author":"Sghedoni","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejmp.2025.105077_b0160","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1088\/0031-9155\/54\/13\/008","article-title":"Dose conversion coefficients for electron exposure of the human eye lens","volume":"54","author":"Behrens","year":"2009","journal-title":"Phys Med Biol"},{"issue":"11","key":"10.1016\/j.ejmp.2025.105077_b0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1088\/0031-9155\/28\/11\/005","article-title":"A short atlas of beta-ray spectra","volume":"28","author":"Cross","year":"1983","journal-title":"Phys Medi Bio"},{"key":"10.1016\/j.ejmp.2025.105077_b0170","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1088\/0031-9155\/49\/10\/009","article-title":"Monte Carlo investigation of single cell beta dosimetry for intraperitoneal radionuclide therapy","volume":"49","author":"Syme","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2025.105077_b0175","unstructured":"ICRP Publication 60 1990 Recommendations of the International Commission on Radiological Protection."},{"key":"10.1016\/j.ejmp.2025.105077_b0180","unstructured":"ICRU Report 95, Operational Quantities for External Radiation Exposure (ICRU 2020)."},{"key":"10.1016\/j.ejmp.2025.105077_b0185","unstructured":"D. B. Pelowitz (editor) MCNP6 User's Manual. Los Alamos National Laboratory Tech. Rep. LA-CP-13-00634. Los Alamos, NM, USA. May 2013."},{"key":"10.1016\/j.ejmp.2025.105077_b0190","doi-asserted-by":"crossref","unstructured":"T. Sato et al., \u201cParticle and Heavy Ion Transport code System, PHITS, version 2.52\u201d, J Nucl Sci Technol 50, 913-923 (2013) PHITS.","DOI":"10.1080\/00223131.2013.814553"},{"key":"10.1016\/j.ejmp.2025.105077_b0195","doi-asserted-by":"crossref","unstructured":"Keith T Griffin , Yeon Soo Yeom , Matthew M Mille , Choonik Lee, Jae Won Jung, Nolan E Hertel, Choonsik Lee Comparison of out-of-field normal tissue dose estimates for pencil beam scanning proton therapy: MCNP6, PHITS, and TOPAS Biomed Phys Eng Express. 2022 23;9(1):10.1088\/2057-1976.","DOI":"10.1088\/2057-1976\/acaab1"},{"issue":"4\u20135","key":"10.1016\/j.ejmp.2025.105077_b0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1524\/ract.2001.89.4-5.337","article-title":"A review of radiation dosimetry applications using the MCNP Monte Carlo code","volume":"89","author":"Solberg","year":"2001","journal-title":"Radiochimica Acta"},{"key":"10.1016\/j.ejmp.2025.105077_b0205","doi-asserted-by":"crossref","unstructured":"Takuya Furuta, Tatsuhiko Sato Medical application of particle and heavy ion transport code system PHITS Vol.: (0123456789)1 3Radiological Physics and Technology (2021) 14:215\u2013225.","DOI":"10.1007\/s12194-021-00628-0"},{"key":"10.1016\/j.ejmp.2025.105077_b0210","unstructured":"ISO\/IEC Guide 98-1:2024 Guide to the expression of uncertainty in measurement."},{"key":"10.1016\/j.ejmp.2025.105077_b0215","unstructured":"https:\/\/physics.nist.gov\/PhysRefData\/Star\/Text\/ESTAR.html (site checked on 29th October 2024)."},{"key":"10.1016\/j.ejmp.2025.105077_b0220","unstructured":"https:\/\/www.nist.gov\/pml\/x-ray-mass-attenuation-coefficients (last checked on 24 June 2025)."},{"issue":"Suppl 1","key":"10.1016\/j.ejmp.2025.105077_b0225","first-page":"S1","article-title":"Iori eye lens dose estimation in peptide receptor radionuclide therapy: monte carlo simulations versus experimental measurements OP-735","volume":"46","author":"Fioroni","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ejmp.2025.105077_b0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rpd\/ncr028","article-title":"H p (0.07) photon dosemeters for eye lens dosimetry: Calibration on a rod vs. a slab phantom","volume":"148","author":"Behrens","year":"2012","journal-title":"Radiat Protect Dosimetry"},{"key":"10.1016\/j.ejmp.2025.105077_b0235","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ejmp.2016.08.010","article-title":"The influence of operator position, height and body orientation on eye lens dose in interventional radiology and cardiology: Monte Carlo simulations versus realistic clinical measurements","volume":"32","author":"Principi","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12149-014-0843-8","article-title":"Harvey Turner Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumors","volume":"28","author":"Phillipe","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ejmp.2025.105077_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-023-00592-1","article-title":"Radiation exposure assessment of nuclear medicine staff administering [177Lu] Lu-DOTA-TATE with active and passive dosimetry","volume":"10","author":"Riveira-Martin","year":"2023","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2025.105077_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00411-017-0721-6","article-title":"Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy","volume":"57","author":"Abuqbeitah","year":"2018","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ejmp.2025.105077_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109240","article-title":"Occupational and ambient radiation exposures from Lu-177 DOTATATE during targeted therapy","volume":"164","author":"Sulieman","year":"2020","journal-title":"Appl Radiat Isotopes"},{"issue":"4","key":"10.1016\/j.ejmp.2025.105077_b0260","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6498\/ac31a2","article-title":"Review of extremity dosimetry in nuclear medicine","volume":"41","author":"Kollaard","year":"2021","journal-title":"J Radiol Prot."}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179725001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179725001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T22:53:58Z","timestamp":1762815238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179725001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"alternative-id":["S1120179725001875"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2025.105077","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monte Carlo study of the eye lens exposure of medical staff administering Sc-47 and Cu-67 labelled radiopharmaceuticals","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2025.105077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105077"}}